Literature DB >> 12928420

Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans.

Juan C Salazar1, Constance D Pope, Timothy J Sellati, Henry M Feder, Thomas G Kiely, Kenneth R Dardick, Ronald L Buckman, Meagan W Moore, Melissa J Caimano, Jonathan G Pope, Peter J Krause, Justin D Radolf.   

Abstract

We used multiparameter flow cytometry to characterize leukocyte immunophenotypes and cytokines in skin and peripheral blood of patients with erythema migrans (EM). Dermal leukocytes and cytokines were assessed in fluids aspirated from epidermal suction blisters raised over EM lesions and skin of uninfected controls. Compared with corresponding peripheral blood, EM infiltrates were enriched for T cells, monocytes/macrophages, and dendritic cells (DCs), contained lower proportions of neutrophils, and were virtually devoid of B cells. Enhanced expression of CD14 and HLA-DR by lesional neutrophils and macrophages indicated that these innate effector cells were highly activated. Staining for CD45RO and CD27 revealed that lesional T lymphocytes were predominantly Ag-experienced cells; furthermore, a subset of circulating T cells also appeared to be neosensitized. Lesional DC subsets, CD11c(+) (monocytoid) and CD11c(-) (plasmacytoid), expressed activation/maturation surface markers. Patients with multiple EM lesions had greater symptom scores and higher serum levels of IFN-alpha, TNF-alpha, and IL-2 than patients with solitary EM. IL-6 and IFN-gamma were the predominant cytokines in EM lesions; however, greater levels of both mediators were detected in blister fluids from patients with isolated EM. Circulating monocytes displayed significant increases in surface expression of Toll-like receptor (TLR)1 and TLR2, while CD11c(+) DCs showed increased expression of TLR2 and TLR4; lesional macrophages and CD11c(+) and CD11c(-) DCs exhibited increases in expression of all three TLRs. These results demonstrate that Borrelia burgdorferi triggers innate and adaptive responses during early Lyme disease and emphasize the interdependence of these two arms of the immune response in the efforts of the host to contain spirochetal infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928420     DOI: 10.4049/jimmunol.171.5.2660

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 3.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

4.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

5.  Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.

Authors:  Marguerite R Kelher; Anirban Banerjee; Fabia Gamboni; Cameron Anderson; Christopher C Silliman
Journal:  Transfusion       Date:  2016-09-25       Impact factor: 3.157

6.  Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.

Authors:  Klemen Strle; Elise E Drouin; Shiqian Shen; Joseph El Khoury; Gail McHugh; Eva Ruzic-Sabljic; Franc Strle; Allen C Steere
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

7.  A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice.

Authors:  Jennifer C Miller; Ying Ma; Jiantao Bian; Kathleen C F Sheehan; James F Zachary; John H Weis; Robert D Schreiber; Janis J Weis
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

9.  Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.

Authors:  Junghee J Shin; Klemen Strle; Lisa J Glickstein; Andrew D Luster; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2010-09-09       Impact factor: 5.156

10.  Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Authors:  Juan C Salazar; Star Duhnam-Ems; Carson La Vake; Adriana R Cruz; Meagan W Moore; Melissa J Caimano; Leonor Velez-Climent; Jonathan Shupe; Winfried Krueger; Justin D Radolf
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.